RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Wakamoto Pharmaceutical Co Stock

Wakamoto Pharmaceutical Co ROA 2024

Wakamoto Pharmaceutical Co ROA

0.01

Ticker

4512.T

ISIN

JP3991200001

In 2024, Wakamoto Pharmaceutical Co's return on assets (ROA) was 0.01, a -55.71% increase from the 0.02 ROA in the previous year.

Wakamoto Pharmaceutical Co Aktienanalyse

What does Wakamoto Pharmaceutical Co do?

Wakamoto Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Wakamoto Pharmaceutical Co's Return on Assets (ROA)

Wakamoto Pharmaceutical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Wakamoto Pharmaceutical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Wakamoto Pharmaceutical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Wakamoto Pharmaceutical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Wakamoto Pharmaceutical Co stock

What is the Return on Assets (ROA) of Wakamoto Pharmaceutical Co this year?

The Return on Assets (ROA) of Wakamoto Pharmaceutical Co is 0.01 undefined this year.

What was the ROA of Wakamoto Pharmaceutical Co compared to the previous year?

The ROA of Wakamoto Pharmaceutical Co has increased by -55.71% compared to the previous year.

What consequences do high ROA have for investors of Wakamoto Pharmaceutical Co?

A high ROA is advantageous for investors of Wakamoto Pharmaceutical Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Wakamoto Pharmaceutical Co?

A low ROA can be unfavorable for investors of Wakamoto Pharmaceutical Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Wakamoto Pharmaceutical Co affect the company?

An increase in ROA of Wakamoto Pharmaceutical Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Wakamoto Pharmaceutical Co impact the company?

A reduction in the ROA of Wakamoto Pharmaceutical Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Wakamoto Pharmaceutical Co?

Some factors that can influence the ROA of Wakamoto Pharmaceutical Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Wakamoto Pharmaceutical Co important for investors?

The ROA of Wakamoto Pharmaceutical Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Wakamoto Pharmaceutical Co take to improve ROA?

To improve ROA, Wakamoto Pharmaceutical Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Wakamoto Pharmaceutical Co pay?

Over the past 12 months, Wakamoto Pharmaceutical Co paid a dividend of 3 JPY . This corresponds to a dividend yield of about 1.21 %. For the coming 12 months, Wakamoto Pharmaceutical Co is expected to pay a dividend of 3 JPY.

What is the dividend yield of Wakamoto Pharmaceutical Co?

The current dividend yield of Wakamoto Pharmaceutical Co is 1.21 %.

When does Wakamoto Pharmaceutical Co pay dividends?

Wakamoto Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Wakamoto Pharmaceutical Co?

Wakamoto Pharmaceutical Co paid dividends every year for the past 2 years.

What is the dividend of Wakamoto Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 3 JPY are expected. This corresponds to a dividend yield of 1.21 %.

In which sector is Wakamoto Pharmaceutical Co located?

Wakamoto Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Wakamoto Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Wakamoto Pharmaceutical Co from 6/1/2024 amounting to 3 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Wakamoto Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Wakamoto Pharmaceutical Co in the year 2023?

In the year 2023, Wakamoto Pharmaceutical Co distributed 3 JPY as dividends.

In which currency does Wakamoto Pharmaceutical Co pay out the dividend?

The dividends of Wakamoto Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Wakamoto Pharmaceutical Co

Our stock analysis for Wakamoto Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wakamoto Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.